RGNX
Regenxbio Inc

2,561
Mkt Cap
$661.14M
Volume
593,150.00
52W High
$13.99
52W Low
$5.04
PE Ratio
-3.68
RGNX Fundamentals
Price
$12.85
Prev Close
$13.06
Open
$13.06
50D MA
$12.08
Beta
1.62
Avg. Volume
636,295.53
EPS (Annual)
-$4.59
P/B
4.03
Rev/Employee
$236,056.66
Loading...
Loading...
News
all
press releases
REGENXBIO (NASDAQ:RGNX) Reaches New 52-Week High - Should You Buy?
REGENXBIO (NASDAQ:RGNX) Sets New 52-Week High - Here's What Happened...
MarketBeat·3d ago
News Placeholder
More News
News Placeholder
Voss Capital LP Boosts Stock Holdings in REGENXBIO Inc. $RGNX
Voss Capital LP raised its position in shares of REGENXBIO Inc. (NASDAQ:RGNX - Free Report) by 47.4% in the second quarter, according to its most recent Form 13F filing with the Securities and...
MarketBeat·4d ago
News Placeholder
REGENXBIO Inc. $RGNX is 22NW LP's 5th Largest Position
22NW LP boosted its position in shares of REGENXBIO Inc. (NASDAQ:RGNX - Free Report) by 38.1% during the second quarter, according to the company in its most recent filing with the Securities and...
MarketBeat·4d ago
News Placeholder
26,773 Shares in REGENXBIO Inc. $RGNX Bought by Rockefeller Capital Management L.P.
Rockefeller Capital Management L.P. acquired a new position in shares of REGENXBIO Inc. (NASDAQ:RGNX - Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the SEC...
MarketBeat·12d ago
News Placeholder
REGENXBIO Inc. (NASDAQ:RGNX) Receives Consensus Recommendation of "Moderate Buy" from Analysts
Shares of REGENXBIO Inc. (NASDAQ:RGNX - Get Free Report) have received an average rating of "Moderate Buy" from the seven analysts that are currently covering the company, Marketbeat.com reports. One...
MarketBeat·14d ago
News Placeholder
REGENXBIO (NASDAQ:RGNX) Trading Up 10.7% After Analyst Upgrade
REGENXBIO (NASDAQ:RGNX) Trading 10.7% Higher Following Analyst Upgrade...
MarketBeat·15d ago
News Placeholder
Brokers Set Expectations for REGENXBIO FY2026 Earnings
REGENXBIO Inc. (NASDAQ:RGNX - Free Report) - Equities researchers at Chardan Capital cut their FY2026 earnings estimates for shares of REGENXBIO in a research note issued to investors on Thursday...
MarketBeat·18d ago
News Placeholder
REGENXBIO (NASDAQ:RGNX) Raised to Hold at Wall Street Zen
Wall Street Zen raised shares of REGENXBIO from a "sell" rating to a "hold" rating in a research note on Monday...
MarketBeat·18d ago
News Placeholder
Savant Capital LLC Invests $226,000 in REGENXBIO Inc. $RGNX
Savant Capital LLC purchased a new position in REGENXBIO Inc. (NASDAQ:RGNX - Free Report) during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm...
MarketBeat·22d ago
News Placeholder
REGENXBIO (NASDAQ:RGNX) Cut to "Sell" at Wall Street Zen
Wall Street Zen cut shares of REGENXBIO from a "hold" rating to a "sell" rating in a report on Sunday...
MarketBeat·26d ago

Latest RGNX News

View

Advertisement|Remove ads.

Advertisement|Remove ads.